Amaero Inc. filed an S-1 registration statement with the SEC to seek an Initial Public Offering listing on Nasdaq, with Baird running the deal.
3 reports, 2 independent
Updated Thu 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amaero Inc. filed an S-1 registration statement with the SEC to seek an Initial Public Offering listing on Nasdaq, with Baird running the deal.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Amaero Inc. IPO aims to fund U.S. expansion and manufacturing base growth.1 source
Amaero Inc. is filing S-1 with the SEC for a Nasdaq IPO, with Baird assisting the deal.1 source
Keep exploring
The entities involved
Related events
- ADARx Pharmaceuticals, Inc. is seeking a public listing via IPO on Nasdaq, having filed the S-1 registration statement with the SEC and appointing Morgan Stanley as joint bookrunner.
- Jones Ventures INTL Acquisition1 Corp. filed its registration statement with the SEC and announced its IPO listing on Nasdaq Global Market.
- Electra Therapeutics is seeking an IPO listing on Nasdaq, retaining TD Cowen as joint bookrunner and filing S-1.
- IPO filings are subject to SEC oversight, involving the Nasdaq stock exchange and the SEC.
- Offering filed with SEC and declared effective for Southern Cross Acquisition II Corp., with IPO expected on Nasdaq Capital Market.